Revenio Group Oyj (LON:0KFH)

Market Cap	595.55M
Revenue (ttm)	88.94M
Net Income (ttm)	15.98M
Shares Out	n/a
EPS (ttm)	0.60
PE Ratio	37.28
Forward PE	29.99
Dividend	0.35 (1.31%)
Ex-Dividend Date	Apr 11, 2025

Volume	448
Average Volume	2,669
Open	26.53
Previous Close	n/a
Day's Range	26.53 - 26.53
52-Week Range	22.40 - 35.74
Beta	1.38
RSI	49.19
Earnings Date	Aug 7, 2025

About Accolade

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for mea...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2001
• Employees: 241
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KFH

Financial Performance

In 2024, Revenio Group Oyj's revenue was 103.82 million, an increase of 7.27% compared to the previous year's 96.79 million. Earnings were 18.50 million, a decrease of -3.20%.